The Utilization, Expenditure, and Price of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the US Medicaid Programs: Trends Over a 31 Year Period-Reference-Cited by-同舟云学术

The Utilization, Expenditure, and Price of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the US Medicaid Programs: Trends Over a 31 Year Period

Published:2023-01 Issue: Volume:370 Page:412-418
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Almadfaa Rawan O.,Wigle Patricia R.,Hincapie Ana L.,Guo Jeff J.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. International society of hypertension global hypertension practice guidelines;Unger;J. Hypertens.,2020

2. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and Management of High Blood Pressure in adults;Whelton;J. Am. Coll. Cardiol.,2018

3. Angiotensin converting enzyme inhibitors (ACEI);Herman,2022

4. Indications for and utilization of angiotensin receptor II blockers in patients at high cardiovascular risk;Farsang;Vasc. Health Risk Manag.,2011

5. Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension;Matchar;Ann. Intern. Med.,2008

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Changes in serum potassium with concomitant administration of renin-angiotensin system agents and potassium-sparing diuretics: U.S. cohort study using electronic health record data;JAPhA Pharmacotherapy;2024-01

2. Economics of Team-Based Care for Blood Pressure Control: Updated Community Guide Systematic Review;American Journal of Preventive Medicine;2023-10